Concurrent Investment Advisors’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.84M Buy
13,502
+1,519
+13% +$326K 0.02% 607
2026
Q1
$2.65M Buy
11,983
+420
+4% +$103K 0.03% 530
2025
Q4
$2.93M Buy
11,563
+2,256
+24% +$567K 0.03% 464
2025
Q3
$2.3M Sell
9,307
-58
-0.6% -$13.9K 0.04% 428
2025
Q2
$2.25M Buy
9,365
+466
+5% +$109K 0.04% 400
2025
Q1
$2.02M Buy
8,899
+1,279
+17% +$281K 0.05% 364
2024
Q4
$1.57M Sell
7,620
-32
-0.4% -$7.02K 0.04% 381
2024
Q3
$1.86M Buy
7,652
+323
+4% +$75.5K 0.05% 335
2024
Q2
$1.61M Buy
7,329
+379
+5% +$82.3K 0.05% 330
2024
Q1
$1.56M Sell
6,950
-2,257
-25% -$509K 0.06% 285
2023
Q4
$2.02M Buy
+9,207
New +$1.95M 0.1% 225

Other funds holding STE

Concurrent Investment Advisors's STE Position: Q2 2026 in Review

Concurrent Investment Advisors increased its Steris (STE) stake by 13% in Q2 2026, buying an estimated $326K and bringing the position to 13,502 shares worth $2.84M. The position accounts for 0.02% of the portfolio, ranked #607.

Concurrent Investment Advisors first reported a position in STE in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.93M in Q4 2025. 839 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Concurrent Investment Advisors held 13,502 shares of Steris worth $2.84M as of Q2 2026.
  • Concurrent Investment Advisors bought 1,519 Steris shares in Q2 2026, an estimated $326K.
  • Steris made up 0.02% of Concurrent Investment Advisors's portfolio in Q2 2026, its #607 holding.
  • Concurrent Investment Advisors first reported a position in Steris in Q4 2023 and has held it in 11 quarters since.
  • Concurrent Investment Advisors's Steris position peaked at $2.93M in Q4 2025.
  • 839 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Concurrent Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.